Document Detail


Localization of c-fos-like proteins in the mouse endometrium during the peri-implantation period.
MedLine Citation:
PMID:  1511103     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fos, which collectively refers to protein products of the c-fos proto-oncogene family, was immunohistochemically localized in the mouse uterus to ascertain the effects of steroids on Fos expression in the mouse and to determine the course of Fos expression during normal pregnancy and pseudopregnancy. In ovariectomized mice, Fos was induced in luminal and glandular epithelium and an occasional stromal cell following treatment with 100 ng 17 beta-estradiol (E2). Priming with 2 mg progesterone (P4) for 3 days prior to the administration of 100 ng E2 or giving 100 ng E2 and 2 mg P4 concomitantly induced Fos in the luminal and glandular epithelium with enhanced staining in stromal cells. Priming with P4 before giving E2 had the added effect of inducing Fos at an earlier time point. Progesterone alone failed to induce Fos in any cell type in the uteri of ovariectomized animals. On Days 1 and 2 of pregnancy and pseudopregnancy, Fos was detected in the luminal and glandular epithelium and in the stroma. Staining was decreased by Day 3 and was not detectable by the morning of Day 4. No further staining for Fos was found during subsequent days of pseudopregnancy. On the afternoon of Day 4 of pregnancy, Fos was detected in the epithelium and the antimesometrial stroma. On the morning of Day 5, implantation sites and non-site areas were distinguishable, with Fos present in luminal epithelium and antimesometrial stroma in sites, and in just the luminal epithelium in non-sites. Fos remained in the epithelium of non-sites through Day 7 of pregnancy. In sites on the afternoon of Day 5, staining was found in the luminal epithelium and primary decidual zone. On Day 6, staining was found in the secondary decidual zone, but was absent from the primary zone and epithelium. On Day 7, Fos was also detected in the embryonic trophoblast giant cells and the ectoplacental cone. These results demonstrate that E2 and P4 modulate Fos in the mouse endometrium and that Fos is induced during implantation. Significantly, the embryo appears to induce Fos expression on the afternoon of Day 4, while it is still encased in the zona pellucida.
Authors:
D J Baker; F Nagy; G L Nieder
Related Documents :
2460623 - Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse ...
8527503 - Histological characteristics of the uterine endometrium and corpus luteum during early ...
7619233 - Intercellular adhesion molecule-1 (icam-1) and hla-dr antigens are expressed on endovas...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Biology of reproduction     Volume:  47     ISSN:  0006-3363     ISO Abbreviation:  Biol. Reprod.     Publication Date:  1992 Sep 
Date Detail:
Created Date:  1992-10-01     Completed Date:  1992-10-01     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0207224     Medline TA:  Biol Reprod     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  492-501     Citation Subset:  IM    
Affiliation:
Department of Anatomy, Wright State University School of Medicine, Dayton, Ohio 45435.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Animals
Embryo Implantation*
Endometrium / chemistry*
Epithelium / chemistry
Estradiol / pharmacology
Female
Immunohistochemistry
Mice
Mice, Inbred ICR
Molecular Sequence Data
Ovariectomy
Pregnancy
Progesterone / pharmacology
Proto-Oncogene Proteins c-fos / analysis*
Pseudopregnancy / metabolism
Grant Support
ID/Acronym/Agency:
HD 25236/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Proto-Oncogene Proteins c-fos; 50-28-2/Estradiol; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Kinetics of follicle growth in the prepubertal gilt.
Next Document:  Functional classification of chronic alcoholic hepatopathy in primary care